Clinical Trials Directory

Trials / Completed

CompletedNCT00217100

A Multivitamin Comparison Study in Kidney Transplant Recipients.

Folic Acid for Vascular Outcome Reduction in Transplantation.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study is being done to compare arteriosclerotic cardiovascular disease in kidney transplant recipient taking a standard multivitamin versus those taking a multivitamin augmented by a high dose combination of folic acid, vitamin B12, and vitamin B6.

Detailed description

This is a multicenter, randomized, double-blind controlled clinical trial. The trial has been designed to determine whether total homocysteine lowering treatment with a standard multivitamin augmented by a multivitamin containing no folic acid B12, and vitamin B6, versus treatment with an identical multivitamin containing no folic acid, will reduce the pooled rate of recurrent or new cardiovascular disease outcomes or events. Participants will have a brief visit, at which the participant will have physical measurements, blood pressure and history taken. Urine and blood tests will be performed to determine the levels of homocysteine, vitamins and creatinine. Qualifying participants will be randomly assigned to receive multivitamins containing a high dose of folic acid, vitamin B6, and vitamin B12, or an identical multivitamin containing no folic acid, and estimated average requirement amounts of vitamin B6 and vitamin B12. The participant will be required to return annually throughout the next five years for physical exams, blood and urine tests.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTMultivitamin1 tablet a day
DIETARY_SUPPLEMENTPlacebo1 tablet a day

Timeline

Start date
2004-10-01
Primary completion
2010-02-01
Completion
2010-02-01
First posted
2005-09-22
Last updated
2012-04-25

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00217100. Inclusion in this directory is not an endorsement.